Viewing Study NCT03281551


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-02-21 @ 2:22 PM
Study NCT ID: NCT03281551
Status: UNKNOWN
Last Update Posted: 2017-09-15
First Post: 2017-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma
Sponsor: Pinze Lifetechnology Co. Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-10-01
Start Date Type: ESTIMATED
Primary Completion Date: 2020-09-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2020-11-01
Completion Date Type: ESTIMATED
First Submit Date: 2017-09-09
First Submit QC Date: None
Study First Post Date: 2017-09-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-09-14
Last Update Post Date: 2017-09-15
Last Update Post Date Type: ACTUAL